ClassID:

96740

C07K7/08 - page 4 - CPC Classification

Classification description:

Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 12 to 20 amino acids

Recent Application in this class:
#901
20210371466
2021-12-02

α4β7 thioether peptide dimer antagonists

#902
20210371465
2021-12-02

METHOD OF USING A TLR9 ANTAGONIST AS AN ANTI-INFLAMMATORY AND ANTI-FIBROTIC AGENT

#903
20210371458
2021-12-02

Tertiary amino lipidated cationic peptides for nucleic acid delivery

#904
20210369867
2021-12-02

Lipid nanoparticle formulations comprising lipidated cationic peptide compounds for nucleic acid delivery

#905
20210369826
2021-12-02

Personalized immunotherapy against several neuronal and brain tumors

#906
20210369807
2021-12-02

Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making

#907
20210363511
2021-11-25

LYSIN-ANTIMICROBIAL PEPTIDE (AMP) POLYPEPTIDE CONSTRUCTS, LYSINS, ISOLATED POLYNUCLEOTIDES ENCODING SAME AND USES THEREOF

#908
20210363187
2021-11-25

Therapeutic peptides

#909
20210363186
2021-11-25

Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostic and therapeutic delivery

#910
20210363185
2021-11-25

Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

#911
20210363184
2021-11-25

PROCESS FOR PREPARATION OF PURE PLECANATIDE

#912
20210363183
2021-11-25

Artificial intelligence designed antimicrobial peptides

#913
20210361736
2021-11-25

Vista antagonist and methods of use

#914
20210355208
2021-11-18

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF

#915
20210355164
2021-11-18

Peptide capable of binding to biomarker for inflammatory and metabolic diseases, and use thereof

#916
20210353742
2021-11-18

Immunogenic composition and use thereof

#917
20210353728
2021-11-18

Peptides and combination of peptides for use in immunotherapy against various cancers

#918
20210347913
2021-11-11

Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK7) and immune cells expressing such

#919
20210347886
2021-11-11

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF

#920
20210347824
2021-11-11

ANTIGENIC PEPTIDES AND USES THEREOF FOR DIAGNOSING AND TREATING AUTISM

#921
20210347823
2021-11-11

METHODS OF PHYSICOCHEMICAL-GUIDED PEPTIDE DESIGN AND NOVEL PEPTIDES DERIVED THEREFROM

#922
20210347822
2021-11-11

Immunotherapy against several tumors including neuronal and brain tumors

#923
20210347820
2021-11-11

Modified peptide fragments of CAV-1 protein and the use thereof in the treatment of fibrosis

#924
20210346481
2021-11-11

Peptides and combination of peptides for use in immunotherapy against various cancers

#925
20210341491
2021-11-04

Rheumatoid arthritis auto-antibody-bound peptide and application thereof

#926
20210340182
2021-11-04

NOVEL USE OF PEPTIDE FOR INHIBITING FUNCTIONS AND EXPRESSIONS OF MULTIPLE DISEASE BIOMARKERS

#927
20210340181
2021-11-04

Alpha(v)beta(6) integrin-binding peptides and methods of use thereof

#928
20210340180
2021-11-04

Amyloid inhibitory peptides

#929
20210332152
2021-10-28

Peptide fusion protein

#930
20210330800
2021-10-28

Albumin binding peptide conjugates and methods thereof

#931
20210330736
2021-10-28

USE OF A PDE11 OR PDE2 INHIBITOR FOR THE TREATMENT OF PARKINSON'S DISEASE

#932
20210324006
2021-10-21

PEPTIDE COMPOSITIONS AND METHODS FOR INHIBITING NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVITY

#933
20210324004
2021-10-21

Peptides for the treatment of covid-19

#934
20210322575
2021-10-21

LIPID NANOPARTICLE FORMULATIONS COMPRISING LIPIDATED CATIONIC PEPTIDE COMPOUNDS FOR NUCLEIC ACID DELIVERY

#935
20210309748
2021-10-07

ANTI HLA-G SPECIFIC ANTIBODIES

#936
20210309698
2021-10-07

Methods for treatment and diagnosis of non-alcoholic steatohepatitis and/or hepatocellular carcinoma

#937
20210309697
2021-10-07

COMPOSITIONS AND METHODS FOR TREATING CD40-MEDIATED DISEASES

#938
20210308239
2021-10-07

THERAPEUTIC INDUCTION OF TOLERANCE USING RECOMBINANT CELL SURFACE ANTIGENS

#939
20210308182
2021-10-07

Regulatory T cell epitopes

#940
20210301296
2021-09-30

Anti-EGFR1-PD1 targeted/immunomodulatory fusion protein

#941
20210300969
2021-09-30

IL-17A binding peptides and medical uses thereof

#942
20210299326
2021-09-30

Sterilization of self-assembling peptides by irradiation

#943
20210299283
2021-09-30

Peptides and antibodies for detecting changes in alzheimer's disease brain and methods of use thereof

#944
20210299264
2021-09-30

CELL-PENETRATING PEPTIDES

#945
20210299263
2021-09-30

Cell-penetrating peptides

#946
20210299210
2021-09-30

Heterotandem bicyclic peptide complexes

#947
20210292368
2021-09-23

Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof

#948
20210292367
2021-09-23

Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers

#949
20210292366
2021-09-23

PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM

#950
20210292365
2021-09-23

Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers

#951
20210292364
2021-09-23

Peptides for use as cell-penetrating peptides

#952
20210290745
2021-09-23

Peptides and combination of peptides for use in immunotherapy against various cancers

#953
20210290744
2021-09-23

Peptides and combination of peptides for use in immunotherapy against various cancers

#954
20210285948
2021-09-16

PEPTIDE MICROARRAYS AND NOVEL BIOMARKERS FOR CELIAC DISEASE

#955
20210284721
2021-09-16

MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF

#956
20210284703
2021-09-16

Encryption device and operation method thereof

#957
20210284692
2021-09-16

Cell-permeable inhibitory agent and methods of use thereof in treatment of cognitive and mood disorders

#958
20210283231
2021-09-16

Peptides and combination of peptides for use in immunotherapy against various cancers

#959
20210277081
2021-09-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#960
20210277072
2021-09-09

PLANT-DERIVED ELASTIN BINDING PROTEIN LIGANDS AND METHODS OF USING THE SAME

#961
20210277062
2021-09-09

CYCLIC PEPTIDE AND A MEDICAMENT, EXTERNAL PREPARATION AND COSMETIC COMPRISING SAID CYCLIC PEPTIDE

#962
20210277061
2021-09-09

Yeats inhibitors and methods of use thereof

#963
20210275669
2021-09-09

PD-1 and CTLA-4 Dual Inhibitor Peptides

#964
20210275656
2021-09-09

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

#965
20210269481
2021-09-02

Peptide for regulating reactivity to serotonin reuptake inhibitor based antidepressant, and use thereof

#966
20210269480
2021-09-02

BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4

#967
20210268105
2021-09-02

SELF-ASSEMBLING PEPTIDE SCAFFOLD

#968
20210268089
2021-09-02

Peptides and combination of peptides for use in immunotherapy against Hepatocellular carcinoma (HCC) and other cancers

#969
20210261620
2021-08-26

Peptide ligands for binding to EphA2

#970
20210261619
2021-08-26

Apelin polypeptides

#971
20210261618
2021-08-26

SYNTHETIC PEPTIDE SP2 AND APPLICATION THEREOF

#972
20210261617
2021-08-26

Compstatin analogs with increased solubility and improved pharmacokinetic properties

#973
20210261614
2021-08-26

Immunotherapy against several tumors including neuronal and brain tumors

#974
20210260150
2021-08-26

Dry powder formulation of caveolin-1 peptides and methods of use thereof

#975
20210260123
2021-08-26

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#976
20210260122
2021-08-26

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#977
20210255174
2021-08-19

Methods for detection of botulinum neurotoxin

#978
20210253708
2021-08-19

VISTA Antagonist and Methods of Use

#979
20210253641
2021-08-19

EGFRvIII immunogen and methods for using same

#980
20210253640
2021-08-19

Immunotherapy against several tumors including lung cancer

#981
20210253639
2021-08-19

HETERODIMERIC PEPTIDE REAGENTS AND METHODS

#982
20210253637
2021-08-19

Immunotherapy against several tumors including neuronal and brain tumors

#983
20210253636
2021-08-19

Tandem repeat cancer-targeting peptides for molecular conjugation or engineering and uses thereof in cancer theranostics

#984
20210252100
2021-08-19

Protein interfaces

#985
20210252066
2021-08-19

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#986
20210252065
2021-08-19

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#987
20210252064
2021-08-19

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

#988
20210246168
2021-08-12

Peptides for specific inhibition of Jag 1-Notch 1 pathway

#989
20210246167
2021-08-12

Modulation of complement activity

#990
20210246166
2021-08-12

MASP inhibitory compounds and uses thereof

#991
20210238277
2021-08-05

Erythrocyte-binding therapeutics

#992
20210238274
2021-08-05

MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)

#993
20210238244
2021-08-05

OFF-THE-SHELF CANCER VACCINES

#994
20210238234
2021-08-05

Elicitor peptides having disrupted hypersensitive response box and use thereof

#995
20210238228
2021-08-05

Stapled H2 pyrin peptides

#996
20210238227
2021-08-05

Immunotherapy against several tumors including neuronal and brain tumors

#997
20210236647
2021-08-05

Peptide-conjugated nanoparticles for targeting, imaging, and treatment of prostate cancer

#998
20210230227
2021-07-29

Peptide for treating cancer

#999
20210230226
2021-07-29

Anticancer peptides

#1000
20210228697
2021-07-29

Personalized immunotherapy against several neuronal and brain tumors

#1001
20210228690
2021-07-29

Anti-inflammatory peptides and composition comprising the same

#1002
20210221862
2021-07-22

APPLICATION OF PEDF-DERIVED SHORT PEPTIDES IN THE TREATMENT OF OSTEOARTHRITIS

#1003
20210221847
2021-07-22

Peptide for treating rheumatoid arthritis and use thereof

#1004
20210221846
2021-07-22

Targeted non-invasive imaging probes of EGFR expressing cells

#1005
20210214726
2021-07-15

Peptide docking vehicle for targeted nucleic acid delivery

#1006
20210214405
2021-07-15

Peptide, method and composition for melanin polymerization and hair darkening

#1007
20210213161
2021-07-15

SELF-ASSEMBLING PEPTIDE GEL FORMULATION AND METHODS OF USE

#1008
20210213096
2021-07-15

MEANS AND METHODS FOR TREATING BACTERIAL INFECTIONS

#1009
20210212281
2021-07-15

Method for promoting nodulation in plants

#1010
20210206817
2021-07-08

Metabolically Stable Apelin Analogs in the Treatment of Disease Mediated by the Apelin Receptor

#1011
20210206812
2021-07-08

Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses

#1012
20210206806
2021-07-08

PEPTIDIC LINKER WITH REDUCED POST-TRANSLATIONAL MODIFICATION

#1013
20210206805
2021-07-08

CARDIAC-SPECIFIC TARGETING-PEPTIDE (CTP), COMPOSITIONS, AND USES THEREOF

#1014
20210205406
2021-07-08

FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE

#1015
20210199654
2021-07-01

ARRAY AND METHOD OF USE

#1016
20210198343
2021-07-01

Peptidic TGF-beta antagonists

#1017
20210198334
2021-07-01

Anti-Tumour Response to Modified Self-Epitopes

#1018
20210198333
2021-07-01

EphA2 T-cell epitope agonists and uses therefore

#1019
20210198329
2021-07-01

Peptides for targeting LRP6-overexpressed cells

#1020
20210198320
2021-07-01

Cell-penetrating compstatin analogs and uses thereof

#1021
20210198318
2021-07-01

Methods and compositions for treating diseases and conditions associated with gonadotropin releasing hormone receptor

#1022
20210196784
2021-07-01

PEPTIDES FOR USE IN PROMOTING TRANSPORT OF GLUCOSE

#1023
20210188929
2021-06-24

Peptides and nanoparticle formulations thereof

#1024
20210188913
2021-06-24

MODIFIED EPITOPES FOR BOOSTING CD4+ T-CELL RESPONSES

#1025
20210188912
2021-06-24

Serpin peptides and methods of using the same

#1026
20210188910
2021-06-24

Peptides and uses thereof for treating cancer

#1027
20210179665
2021-06-17

COLLECTIONS OF PEPTIDES, PEPTIDE AGENTS, AND METHODS OF USE THEREOF

#1028
20210179664
2021-06-17

Synthetic peptide sp4 and use thereof

#1029
20210177758
2021-06-17

Platform drug delivery system utilizing crystal engineering and theanine dissolution

#1030
20210170073
2021-06-10

Self-assembling peptides comprising non-Ionic polar amino acids

#1031
20210170058
2021-06-10

Modified antibody and radioactive metal-labelled antibody

#1032
20210163557
2021-06-03

METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISORDERS AND ALZHEIMER'S DISEASE AND IMPROVING NORMAL MEMORY

#1033
20210163537
2021-06-03

Peptide and use therefor

#1034
20210162041
2021-06-03

Helper epitope peptide and application thereof

#1035
20210155659
2021-05-27

Compounds for use as apelin receptor antagonists

#1036
20210147556
2021-05-20

Methods of inhibiting integrin α9β1 activity

#1037
20210147520
2021-05-20

Methods of diagnosis and treatment of tuberculosis and infection

#1038
20210147505
2021-05-20

PEPTIDES DERIVED FROM PRORELAXIN H1 (RLN1)

#1039
20210147485
2021-05-20

PEPTIDE LIGANDS FOR BINDING TO INTEGRIN

#1040
20210147484
2021-05-20

Bicyclic peptide ligands and uses thereof

#1041
20210147483
2021-05-20

Analogues of hepcidin mimetics with improved in vivo half lives

#1042
20210147482
2021-05-20

PEPTIDE FOR INHIBITING BONE RESORPTION

#1043
20210147481
2021-05-20

PEPTIDE-BASED INHIBITORS OF MARK FAMILY PROTEINS

#1044
20210147478
2021-05-20

Inhibitors of blood coagulation factor XIII

#1045
20210145990
2021-05-20

Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment

#1046
20210145960
2021-05-20

PROPHYLACTIC PROTECTION AGAINST VIRAL INFECTIONS, PARTICULARLY HIV

#1047
20210139911
2021-05-13

ANTISENSE COMPOSITION AND METHOD FOR TREATING MUSCLE ATROPHY

#1048
20210139558
2021-05-13

PEPTIDES

#1049
20210139540
2021-05-13

MULTIVALENT LIGAND-LIPID CONSTRUCTS

#1050
20210139538
2021-05-13

Method of preparing stapled peptides

#1051
20210138025
2021-05-13

CATIONIC PEPTIDES WITH IMMUNOMODULATORY AND/OR ANTI-BIOFILM ACTIVITIES

#1052
20210135268
2021-05-06

ELECTRODE FOR BIOELECTRONICS USING METAL-IMMOBILIZED PEPTIDE EXPRESSING ENZYME

#1053
20210134388
2021-05-06

Hyperstable Constrained Peptides and Their Design

#1054
20210130424
2021-05-06

Dual IL-2R and IL-7R binding compounds

#1055
20210130407
2021-05-06

Synthetic peptides that modulate the NMDA receptor

#1056
20210130406
2021-05-06

PEPTIDE, COMPOSITION, AND METHOD FOR TREATING, PREVENTING, OR AMELIORATING MOOD DISORDER

#1057
20210130405
2021-05-06

Stapled peptides and uses thereof

#1058
20210130404
2021-05-06

PEPTIDE TAG AND TAGGED PROTEIN INCLUDING SAME

#1059
20210128745
2021-05-06

Rapid formation of supramolecular hydrogels by short peptide and bioactive small molecules

#1060
20210127671
2021-05-06

Hypersensitive response elicitor peptides and use thereof

#1061
20210122805
2021-04-29

Fc FUSION PROTEINS COMPRISING NOVEL LINKERS OR ARRANGEMENTS

#1062
20210122799
2021-04-29

Self-assembling peptide for activating human mast cells

#1063
20210122786
2021-04-29

Modulation of structured polypeptide specificity

#1064
20210122785
2021-04-29

PEPTIDE LIGANDS FOR BINDING TO IL-17

#1065
20210122784
2021-04-29

PEPTIDES DERIVED FROM SOLUTE CARRIER FAMILY 45 MEMBER 2 (SLC45A2) AND USES THEREOF

#1066
20210121551
2021-04-29

PEPTIDES DERIVED FROM MELANOMA-ASSOCIATED ANTIGEN C2 (MAGEC2) AND USES THEREOF

#1067
20210115087
2021-04-22

CYCLIC PEPTIDE INHIBITORS OF HEDGEHOG PROTEINS

#1068
20210107943
2021-04-15

Co-assembly peptides, nanostructures, and methods of making and using the same

#1069
20210107942
2021-04-15

TISSUE PROTECTIVE PEPTIDES AND PEPTIDE ANALOGS FOR PREVENTING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH TISSUE DAMAGE

#1070
20210107941
2021-04-15

NOVEL CELL EPITOPES AND COMBINATION OF CELL EPITOPES FOR USE IN THE IMMUNOTHERAPY OF MYELOMA AND OTHER CANCERS

#1071
20210107940
2021-04-15

14-3-3 targeting peptides for cancer treatment

#1072
20210106665
2021-04-15

CD200 inhibitors and methods of use thereof

#1073
20210106624
2021-04-15

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

#1074
20210106623
2021-04-15

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#1075
20210102183
2021-04-08

Engineered cascade components and cascade complexes

#1076
20210101939
2021-04-08

Modified antimicrobial peptide derived from an arginine-rich domain

#1077
20210101934
2021-04-08

Bovine adrenal medulla peptide 8-22 compounds and methods of use thereof for treating pain

#1078
20210101933
2021-04-08

Multimeric bicyclic peptide ligands

#1079
20210101932
2021-04-08

BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR PD-L1

#1080
20210101931
2021-04-08

Methods and compositions useful for inhibiting growth of certain bacteria

#1081
20210100238
2021-04-08

Compositions and methods for reducing ice crystal formation

#1082
20210094985
2021-04-01

Peptide compositions and methods of use

#1083
20210093732
2021-04-01

PEPTIDES DERIVED FROM TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY M MEMBER 1 (TRPM1), COMPLEXES COMPRISING SUCH PEPTIDES BOUND TO MHC MOLECULES

#1084
20210093728
2021-04-01

Proteoglycan mimetics for enhanced wound healing, angiogenesis, and vascular repair

#1085
20210087244
2021-03-25

Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide

#1086
20210087243
2021-03-25

Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide

#1087
20210087232
2021-03-25

D-ENANTIOMERIC PEPTIDES FOR ANTI-INFLAMMATORY TREATMENT OF AMYOTROPIC LATERAL SCLEROSIS (ALS) AND OTHER DISEASES DRIVEN BY NEURO-INFLAMMATION

#1088
20210087231
2021-03-25

TLR9 inhibitors to suppress inflammatory response to pathogens

#1089
20210087230
2021-03-25

Peptides for treatment and prevention of nonalcoholic fatty liver disease and fibrosis

#1090
20210087229
2021-03-25

Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostics and therapeutic

#1091
20210085807
2021-03-25

METAL-BINDING PEPTIDE AND USE THEREOF

#1092
20210085767
2021-03-25

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS

#1093
20210085757
2021-03-25

Anti-inflammatory peptides and composition comprising the same

#1094
20210085750
2021-03-25

Phage-peptide constructs for stimulating an immune response against CD47

#1095
20210084907
2021-03-25

Bioactive peptides having detrimental effects on pest slugs

#1096
20210079077
2021-03-18

Erythrocyte-binding therapeutics

#1097
20210079045
2021-03-18

Bicyclic peptide ligands with detectable moieties and uses thereof

#1098
20210079044
2021-03-18

Bis-thioether stapled peptides as inhibitors of PRC2 function

#1099
20210079043
2021-03-18

Modulation of structured polypeptide specificity

#1100
20210079042
2021-03-18

Peptide hydrogels and use thereof

#1101
20210079040
2021-03-18

METHODS AND COMPOSITIONS FOR TREATMENT OF CARTILAGE AND DISC TISSUE PATHOLOGIES

#1102
20210077566
2021-03-18

Peptides Having Anti-Inflammatory Properties

#1103
20210071249
2021-03-11

DIAGNOSTIC METHOD AND THERAPY

#1104
20210071196
2021-03-11

Peptides that block transmission of orthotospoviruses and methods of using the same

#1105
20210070816
2021-03-11

Surfactant adhesive composition

#1106
20210070805
2021-03-11

CD40 targeted peptides and uses thereof

#1107
20210070804
2021-03-11

Myotoxin-neutralizing peptides

#1108
20210070803
2021-03-11

Modified peptides and associated methods of use

#1109
20210070802
2021-03-11

Selective targeting of apoptosis proteins by structurally-stabilized and/or cysteine-reactive NOXA peptides

#1110
20210069287
2021-03-11

Heterotandem bicyclic peptide complex

#1111
20210062167
2021-03-04

Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate

#1112
20210061893
2021-03-04

Diagnostic kit

#1113
20210061860
2021-03-04

Peptide-compound cyclization method

#1114
20210061858
2021-03-04

Immunogenic composition

#1115
20210060116
2021-03-04

Methods of reducing neuroinflammation or toxicity induced by amyloid beta (abeta) using glucocorticoid induced leucine zipper (GILZ) analog peptides

#1116
20210054081
2021-02-25

Anti HLA-G specific antibodies

#1117
20210054080
2021-02-25

PEPTIDES

#1118
20210054027
2021-02-25

Catheter injectable cyclic peptide pro-gelators for myocardial tissue engineering

#1119
20210047371
2021-02-18

PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM

#1120
20210047370
2021-02-18

Functional polypeptide and its application thereof in preparing medicament for preventing and treating pulmonary fibrosis

#1121
20210047366
2021-02-18

ANDRIAS DAVIDIANUS CARTILAGE PREPARATION

#1122
20210046145
2021-02-18

Bicyclic peptide ligands and uses thereof

#1123
20210040230
2021-02-11

Methods and Compositions for the Treatment of Autoimmune and Inflammatory Diseases

#1124
20210040154
2021-02-11

Heterotandem bicyclic peptide complex

#1125
20210038703
2021-02-11

Cancer Antigen Peptide

#1126
20210038678
2021-02-11

Compositions comprising cyclic peptides derived from an A-beta peptide

#1127
20210038528
2021-02-11

Nucleic acid nanocapsules for drug delivery and targeted gene knockdown

#1128
20210032301
2021-02-04

PEPTIDES

#1129
20210032292
2021-02-04

Treatments for Gastrointestinal Disorders

#1130
20210032291
2021-02-04

Compstatin Analogs With Improved Pharmacokinetic Properties

#1131
20210032290
2021-02-04

Peptides and nanoparticles for intracellular delivery of molecules

#1132
20210032289
2021-02-04

Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods

#1133
20210032288
2021-02-04

Peptides for cancer treatment

#1134
20210030883
2021-02-04

Compositions and methods for transport across the blood brain barrier

#1135
20210030817
2021-02-04

Methods for making and using antimicrobial peptides

#1136
20210024591
2021-01-28

Targeting G3BP aggregation to prevent neurodegeneration

#1137
20210024236
2021-01-28

FILL-FINISH PROCESS FOR PEPTIDE SOLUTIONS

#1138
20210023189
2021-01-28

Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)

#1139
20210017402
2021-01-21

ANTI-FOULING PAINTS AND COATINGS

#1140
20210017230
2021-01-21

Compositions for expanding regulatory T cells (Treg), and treating autoimmune and inflammatory diseases and conditions

#1141
20210017227
2021-01-21

PEPTIDES

#1142
20210017226
2021-01-21

METHOD OF GENERATING INTERACTING PEPTIDES

#1143
20210015948
2021-01-21

Manganese-based chelate conjugates for molecular MR imaging

#1144
20210009639
2021-01-14

INSULIN LIKE GROWTH FACTOR BINDING PROTEIN BIOACTIVE PEPTIDE FRAGMENTS

#1145
20210009638
2021-01-14

Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases

#1146
20210008189
2021-01-14

Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)

#1147
20210008159
2021-01-14

Peptides with anti-cancer activity

#1148
20210008154
2021-01-14

Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells

#1149
20210002622
2021-01-07

Engineered cascade components and cascade complexes

#1150
20210002330
2021-01-07

Metal nanocluster scaffolds

#1151
20210002329
2021-01-07

Structure-based peptide inhibitors of α-synuclein aggregation

#1152
20210000962
2021-01-07

Bone fracture repair by targeting of agents that promote bone healing

#1153
20210000948
2021-01-07

PD-1 Peptide Inhibitors

#1154
20200407406
2020-12-31

Peptides and methods for the treatment of diabetes

#1155
20200407397
2020-12-31

Compositions and methods for inhibiting lactate dehydrogenase a activity

#1156
20200405831
2020-12-31

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS

#1157
20200405803
2020-12-31

PD-1 peptide inhibitors

#1158
20200399327
2020-12-24

METHODS FOR TREATING PSYCHIATRIC DISORDERS OR SYMPTOMS THEREOF USING NCAM PEPTIDE MIMETICS

#1159
20200399320
2020-12-24

Chimeric polypeptides and uses thereof

#1160
20200399318
2020-12-24

PEPTIDE INHIBITORS OF PHOSPHOGLYCERATE MUTASE AND METHODS OF USE

#1161
20200399316
2020-12-24

Peptide conjugates

#1162
20200399315
2020-12-24

Ultra-pure agonists of guanylate cyclase C, method of making and using same

#1163
20200399314
2020-12-24

IL-2alpha receptor subunit binding compounds

#1164
20200399313
2020-12-24

Compositions and methods for inhibiting CD279 interactions

#1165
20200399312
2020-12-24

Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies

#1166
20200399311
2020-12-24

Peptide based PCSK9 vaccine

#1167
20200399310
2020-12-24

SELF-ASSEMBLING PEPTIDE COMPOSITIONS

#1168
20200399309
2020-12-24

THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS

#1169
20200397912
2020-12-24

Method for conjugating antibody and physiologically active substance

#1170
20200397889
2020-12-24

Influenza peptides and compositions

#1171
20200397879
2020-12-24

Peptides and T cells for use in immunother[[r]]apeutic treatment of various cancers

#1172
20200392193
2020-12-17

FUSION PROTEIN

#1173
20200392186
2020-12-17

Compounds and methods for treating tight junction permeabtility

#1174
20200392185
2020-12-17

Compositions and methods of inhibiting the binding of plasma IgG autoantibodies to serotonin 2A receptor

#1175
20200392184
2020-12-17

Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapy

#1176
20200392183
2020-12-17

Immunogenic WT-1 peptides and methods of use thereof

#1177
20200386755
2020-12-10

Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom

#1178
20200385705
2020-12-10

NOVEL METHODS FOR DISPLAYING CYCLIC PEPTIDES ON BACTERIOPHAGE PARTICLES

#1179
20200385457
2020-12-10

MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)

#1180
20200385440
2020-12-10

MODIFIED BISPECIFIC T CELL RECEPTORS

#1181
20200385429
2020-12-10

Antimicrobial peptides and methods of using same

#1182
20200385426
2020-12-10

Signal molecules as cell penetration agents

#1183
20200385425
2020-12-10

Pharmaceutically acceptable salts of polypeptides and methods of inhibiting the interaction between psd-95 and n-methyl-d-aspartic acid receptor (nmdar)

#1184
20200385423
2020-12-10

USE OF EXCITATORY NERVE INJURY-RELATED POLYPEPTIDE IN PREVENTING, ALLEVIATING OR TREATING PAIN

#1185
20200384071
2020-12-10

Chloride salt of TAT-NR2B9C

#1186
20200384068
2020-12-10

FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE

#1187
20200377553
2020-12-03

Methods of making anti-GP41 antibody-specific capture agents

#1188
20200376103
2020-12-03

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS

#1189
20200376092
2020-12-03

FRAGMENTS OF P97 AND USES THEREOF

#1190
20200370137
2020-11-26

Engineering AAV

#1191
20200369766
2020-11-26

LAG3 binding peptides

#1192
20200369753
2020-11-26

GRP78-derived peptide for identifying high-efficiency stem cells

#1193
20200369750
2020-11-26

HISTAMINE-RELEASING FACTOR (HRF), HRF-RECEPTOR AND METHODS OF MODULATING INFLAMMATION

#1194
20200369727
2020-11-26

COMPOSITION AND METHOD FOR TREATING A PATIENT HAVING LIVER CIRRHOSIS

#1195
20200369726
2020-11-26

Peptides and other agents for treating pain and increasing pain sensitivity

#1196
20200368364
2020-11-26

CYSTEINE PEPTIDE-ENABLED ANTIBODIES

#1197
20200368345
2020-11-26

Methods and compositions for preventing influenza infection

#1198
20200368338
2020-11-26

CONJUGATE OF WT1-DERIVED PEPTIDES AND COMPOSITION COMPRISING THE SAME

#1199
20200362016
2020-11-19

Molecular Size of Elastin-Like Polypeptide Delivery System for Therapeutics Modulates Deposition in the Placenta

#1200
20200361993
2020-11-19

Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases